Dicerna Pharmaceuticals, Inc. DRNA
Set alert
38.22 +38.22 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 2.98B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -19.11
- Beta
- 0.79
- Short ratio
- 0.84
- Inst. own
- 88.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2021
- 50-d avg
- 31.45
- 200-d avg
- 28.97
- 1y target
- 38.25
Ownership
Held by insiders 7.43%
Held by institutions 88.54%
Float held by institutions 95.65%
Institutions 269
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RTW Investments LP | 9.70% | 7,582,396 | 152.86M | Sep 29, 2021 |
| Blackrock Inc. | 7.38% | 5,763,585 | 116.19M | Sep 29, 2021 |
| State Street Corporation | 4.97% | 3,886,181 | 78.35M | Sep 29, 2021 |
| Vanguard Group, Inc. (The) | 4.74% | 3,707,210 | 74.74M | Sep 29, 2021 |
| Bain Capital Life Sciences Investors, LLC | 3.94% | 3,080,237 | 62.10M | Sep 29, 2021 |
| Price (T.Rowe) Associates Inc | 3.43% | 2,682,596 | 54.08M | Sep 29, 2021 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 3.23% | 2,526,829 | 50.94M | Sep 29, 2021 |
| Vanguard Total Stock Market Index Fund | 2.51% | 1,963,234 | 39.58M | Sep 29, 2021 |
| iShares Russell 2000 ETF | 2.07% | 1,618,173 | 33.67M | Oct 30, 2021 |
| Price (T.Rowe) New Horizons Fund | 1.43% | 1,117,136 | 22.52M | Sep 29, 2021 |
| Vanguard Explorer Fund, Inc. | 1.42% | 1,105,726 | 41.48M | Jul 30, 2021 |
| Vanguard Extended Market Index Fund | 1.21% | 944,801 | 19.05M | Sep 29, 2021 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARADHYE SHREERAM | Officer | Conversion of Exercise of derivative security | Dec 14, 2021 | 6,973 |
| BROWN BOB D | Officer | Conversion of Exercise of derivative security | Dec 14, 2021 | 2,367 |
| BUCHI J. KEVIN CPA | Director | Conversion of Exercise of derivative security | Jun 2, 2021 | 4,666 |
| CIAPPENELLI ROBERT D | Officer | Conversion of Exercise of derivative security | Dec 14, 2021 | 14,813 |
| FAMBROUGH DOUGLAS M | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 14, 2021 | 231,431 |
| KOZIN MARC D | Director | Purchase | Aug 9, 2021 | 11,333 |
Held by funds
1 US ETFs and mutual funds hold DRNA · largest positions
| Fund | Value held | Weight in fund |
|---|---|---|
| STSB | 0.16% |